tracekey as an agile company

Since 2013 we work in agil teams.

How Scrum and Co. help us to use our resources effectively Global compliance is essential for the pharmaceutical industry. Therefore, companies need serialization providers, whose offer covers all requirements on a global level, to implement the numerous regulations. As an agile company, tracekey can ensure this offer with significantly fewer resources as many larger software […]

Read More… from tracekey as an agile company


Update: Serialization in Russia

Since 1st July 2020, Russian Federal Law No. 425-FZ (Decree No. 1556) must be officially implemented by pharmaceutical manufacturers. Shortly before the deadline, the pharmaceutical industry tried to obtain a postponement. The new legislation, which will gradually be extended to include clothing, tobacco, and perfume, among others, is intended to prevent counterfeit medicines and black-market […]

Read More… from Update: Serialization in Russia


It doesn’t always have to be the big ones – why it is worthwhile for mid-sized companies to fall back on smaller software providers

If you think of business software, the well-known names of large software manufacturers come to mind, but it is worth looking beyond the end of one’s nose especially for small and medium-sized companies. For them, smaller providers mean service at eye level as well as specialized and clear offers. No matter in which field, digital […]

Read More… from It doesn’t always have to be the big ones – why it is worthwhile for mid-sized companies to fall back on smaller software providers


Brexit: Pharmaceutical industry particularly affected by No-Deal Brexit

The day of the Brexit – March 29 – is slowly approaching and there is still no regulated withdrawal insight. The pharmaceutical industry would be particularly affected by hard Brexit. Without regulated conditions and joint agreements, a complex situation would arise for the chemical and pharmaceutical industries, which could even lead to supply bottlenecks. A […]

Read More… from Brexit: Pharmaceutical industry particularly affected by No-Deal Brexit